A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

Published:2018-10 Issue: Volume:102 Page:95-102
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Reni Michele,Zanon Silvia,Balzano Gianpaolo,Passoni Paolo,Pircher Chiara,Chiaravalli Marta,Fugazza Clara,Ceraulo Domenica,Nicoletti Roberto,Arcidiacono Paolo Giorgio,Macchini Marina,Peretti Umberto,Castoldi Renato,Doglioni Claudio,Falconi Massimo,Partelli Stefano,Gianni Luca

Funder

Celgene

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Cancer statistics, 2017;Siegel;Cancer J Clin,2017

2. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial;Reni;Lancet Oncol,2005

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

4. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

5. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial;Loehrer;J Clin Oncol,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence;Surgery;2024-08

2. SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases;Practical Radiation Oncology;2024-07

3. Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life;Digestive and Liver Disease;2024-07

4. How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review;Journal of Modern Oncology;2024-02-21

5. Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy;Digestive and Liver Disease;2024-02